Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine

Keyphrases

• Hyperglycemia 100%
• Insulin Sensitivity 100%
• Pressors 100%
• Steady State 66%
• Insulin Action 66%
• Resistance to Insulin 66%
• Vasopressors 33%
• Improved Outcomes 33%
• Blood Glucose 33%
• Insulin 33%
• Hyperinsulinemic 33%
• Clamping Method 33%
• Critically Ill Patients 33%
• Healthy Adults 33%
• Mean Arterial Pressure 33%
• Euglycaemia 33%
• C-peptide Levels 33%
• Acutely Ill Patients 33%
• Insulin Peptides 33%
• Cortisol Level 33%
• Hyperinsulinemic-euglycemic Clamp 33%
• Euglycemic 33%
• Glucose Infusion Rate 33%
• Whole-body Insulin Sensitivity 33%
• Insulin Hormone 33%
• Diurnal Variation 33%
• Endogenous Factors 33%
• Norepinephrine Infusion 33%
• Long Swings 33%

Biochemistry, Genetics and Molecular Biology

• Insulin Sensitivity 100%
• Low Drug Dose 100%
• Norepinephrine 100%
• Hyperglycemia 50%
• Secretion (Process) 33%
• Steady State 33%
• Cytokine 16%
• Normal Human 16%
• Glucose Blood Level 16%
• C-Peptide 16%
• Mean Arterial Pressure 16%
• Circadian Rhythm 16%
• Cortisol 16%